| Stock | Price | 52 Week Range | Marketcap | EPS | Dividend Yield | Chart (24H) | Sector | Employees | Last Updated |
|---|---|---|---|---|---|---|---|---|---|
 280585 AHS | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | |||
| $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | ||||
| $17.32 | 222.05M | 1.02 | 0.00% | Energy | 450 | 3 hours ago | |||
| $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | ||||
| $7.38 | 234.19M | 0.86 | 11.44% | Real Estate | 0 | 3 hours ago | |||
 756474 PRX | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | |||
| $34.46 | 965.93M | 0.56 | 3.95% | Consumer Cyclical | 5,700 | 3 hours ago |
Topic and Theme
Time to get excited, folks! Today, we unveil eight “Triple A” stocks that have passed the rigorous scrutiny of the Portfolio Grader system—an evaluation platform that dives into over 4,000 stocks, unearthing only the crème de la crème. This isn’t just about numbers; it’s about you, your financial independence, your avenue to achieving outsized returns.
Every week, the Portfolio Grader system assesses roughly 5,000 companies. The latest evaluation saw only eight stocks earning “A” grades in every main category: Total Grade, Overall Fundamental Grade, and Quantitative Grade. This elite cadre, which we dub “Triple A” stocks, promises to align with your aspirations of autonomy and high-return investments.
Detailed Analysis of Each Stock
Editor's Note: Analysis and insight for this article were originally sourced from our friends at InvestorPlace
AMN Healthcare (NYSE: AHS)
Industry: Healthcare Staffing
AMN Healthcare, a leader in healthcare staffing, recruits nurses, physicians, and other healthcare professionals for temporary or permanent positions in the United States. The company’s remarkable price surge of 25.7% since January 1 eclipses the S&P 500’s own impressive 12.9% gain. Clearly, AHS isn’t just another stock; it’s a beacon signaling future growth.
Investment Rationale: The burgeoning demand for healthcare professionals, driven by demographic shifts like an aging population, bodes well for AMN Healthcare. As the U.S. escalates its need for temporary and permanent healthcare staff, AMN stands ready to capitalize on this trend, fortifying its position as a sector leader. For more details, explore Portfolio Grader’s complete analysis of AHS stock.
Analyst Ratings Table:
| Stock | Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|---|
| AHS | HOLD | 15.88 USD | 15.43 USD | 1.45% | 8 |
Summary of Analysts’ Outlook:
The consensus rating for AHS is HOLD, suggesting that most analysts do not expect significant growth in the short term. The average price target of $15.88 USD implies a potential gain of 1.45% over the current price of $15.43 USD. This outlook is based on the ratings of 8 analysts listed in the sources.
Alon USA Energy (NYSE: ALJ)
Industry: Petroleum Refining and Marketing
Alon USA Energy has seen an 11.4% boost since the start of the year, driven by a strategic focus on key regions such as the South Central, Southwestern, and Western U.S.
Investment Rationale: ALJ’s operational prowess in these crucial areas ensures a stable demand for petroleum products, buttressed by its refined supply chain and marketing capabilities. Thus, it stands as a compelling choice amid the oil market’s inherent volatility. For more information, get Portfolio Grader’s complete analysis of ALJ stock.
Analyst Ratings Table:
| Metric | Value |
|---|---|
| Consensus Rating | No data available |
| Average Price Target | No data available |
| Current Price | No data available |
| Potential Gain | No data available |
| Number of Ratings | No data available |
Summary of Analyst Outlook:
The sources do not provide specific analyst ratings, price targets, or other forecasting information for ALJ. The lack of data suggests that there are currently no reliable analyst projections available for ALJ Regional Holdings.
Geospace Technologies Corp. (NASDAQ: GEOS)
Industry: Seismic Data Acquisition and Processing Equipment
Geospace Technologies has edged up modestly by 0.8% since January 1. This may seem insignificant at first glance, but the strategic importance of its niche in seismic data for monitoring oil and gas reservoirs sets it apart.
Investment Rationale: As global energy exploration intensifies, GEOS’s specialized offerings in seismic data acquisition and processing become even more vital. Investors looking to tap into the burgeoning infrastructure of energy exploration technologies should see GEOS as a hidden gem. The Portfolio Grader’s complete analysis of GEOS stock offers deeper insights.
Analyst Ratings Table:
| Metric | Value |
|---|---|
| Consensus Rating | Hold |
| Average Price Target | $3.00 |
| Current Price | $2.59 |
| Potential Gain | 15.65% |
| Number of Ratings | 4 |
Summary of Analyst Outlook:
The consensus rating for GEOS is Hold, indicating a neutral view from analysts. The average price target is $3.00, representing a potential gain of 15.65% from the current price of $2.59. This prediction is based on the ratings of 4 analysts who have issued specific price targets and ratings for GEOS in the recent past.
Liberty Media Corp. Class A (NASDAQ: LMCA)
Industry: Media, Communications, and Entertainment
Liberty Media Corp. might not have given specific performance metrics this time, but their diversified portfolio in media, communications, and entertainment speaks volumes.
Investment Rationale: Liberty Media’s broad interests ensure it can withstand market fluctuations while providing ample growth opportunities. This diversification makes LMCA an enticing investment for those aiming to balance risk and capitalize on the dynamic shifts in media and entertainment sectors. Learn more with the Portfolio Grader’s in-depth analysis of LMCA stock.
Analyst Ratings Table
| Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|
| Moderate Sell | $10.00 | N/A | N/A | 14 |
Summary of Analyst Outlook:
Analysts are unanimously bearish on Liberty Media Acquisition Corp (LMCA), with a consensus rating of Moderate Sell based on 14 ratings. The average price target is $10.00, indicating a potential increase from the current (unknown) price, but this information is currently unavailable.
AG Mortgage Investment Trust Inc. (NYSE: MITT)
Industry: Real Estate and Mortgage Investment
AG Mortgage Investment Trust has climbed by 9.8% since January 1, and comes with a lucrative 3.2% dividend yield.
Investment Rationale: MITT’s keen strategy of investing in residential mortgage assets dovetails perfectly with the current low-interest-rate environment and robust housing market. With a trailing PE Ratio of 3.70, MITT is not just an income-focused investment but also a value play that’s hard to overlook. Check out the Portfolio Grader’s complete analysis of MITT stock for more information.
Analyst Ratings Table:
| Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|
| Moderate Buy | $7.50 | $6.67 | 12.11% | 2 |
Summary of Analyst Outlook:
The analyst ratings for MITT indicate a generally positive outlook:
– **Consensus Rating**: Among all analysts offering ratings, MITT has a moderate buy consensus. This means that while some analysts are recommending a buy, others are recommending a hold, indicating a mixed view.
– **Price Targets**: The average price target is $7.50, representing a 12.11% increase from the current price of $6.67.
– **Earnings Forecasts**: The next quarter’s earnings estimate is $0.19 with a range of $0.14 to $0.23, indicating potential growth.
– **ETF and Mutual Fund-owned**: MITT is partly owned by ETFs and mutual funds, which may influence its performance and attractiveness to investors.
Par Pharmaceutical (NYSE: PRX)
Industry: Pharmaceuticals
Par Pharmaceutical plays a crucial role by developing, manufacturing, and distributing both generic and branded pharmaceuticals in the U.S., although specific performance metrics were not provided.
Investment Rationale: Given the steady growth in healthcare spending and the sector’s resilience, Par Pharmaceutical’s balanced focus on both generic and branded drugs offers a win-win for investors. The continuous advancements in pharmaceuticals and healthcare reforms are set to drive sustainable growth. For a deeper dive, see Portfolio Grader’s complete analysis of PRX stock.
Analyst Ratings Table
| Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|
| Strong Buy | 43.22 EUR | 32.67 EUR | 10.55% | 18 |
Summary of Analysts’ Outlook:
The consensus rating for PRX is a strong buy, indicating a positive outlook from analysts. The average price target is €43.22 EUR, with a maximum estimate of €53.89 EUR and a minimum estimate of €32.45 EUR. This implies a potential gain of 10.55% based on the current price of €32.67 EUR. Analysts have provided 18 ratings over the past 3 months, showing a unified positive sentiment.
Winnebago Industries (NYSE: WGO)
Industry: Manufacturing of Motor Homes and Recreational Vehicles
Winnebago Industries has enjoyed a substantial 22% increase since January 1, bolstered by the rising popularity of road trips and outdoor activities.
Investment Rationale: As more people seek outdoor recreation, Winnebago’s prospects have never looked brighter. With a trailing PE Ratio of 8.80, this stock offers an enticing balance for both growth and value investors. Explore the Portfolio Grader’s thorough analysis of WGO stock to uncover the full potential of its investment thesis.
Analyst Ratings Table:
| Source | Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|---|
| Tipranks | Moderate Buy | $67.67 | $49.69 | 18.99% | 9 |
| MarketBeat | Moderate Buy | $68.00 | $49.69 (-1.45%) | 36.85% | 7 |
| Yahoo Finance | Sell | Not specified | Not specified | Not specified | 7 |
| ChartMill | Hold | $75.99 | None | None | Not specified |
| Marketscreener | Outperform | $67.44 | $49.68 (-2.85%) | 37.99% | 14 |
Summary of Analyst Outlook:
The analysts’ consensus rating for Winnebago Industries (WGO) is generally a Moderate Buy, indicating a positive outlook for the stock, with an average price target of around $67.44 to $75.99. The current price of WGO is observed at $49.68, pointing to a potential gain of around 18.99% to 37.99%, depending on the source. The differing price targets and optimistic ratings suggest a generally favorable view among analysts, although the current market conditions might influence actual performance.